BioCentury | Apr 8, 2013
Company News
SK Chemicals, TheraVida deal
...TheraVida granted SK Chemicals exclusive rights to develop and commercialize Tolenix ( THVD-201 ) and THVD-202...
...royalties. TheraVida declined to disclose details, and SK Chemicals could not be reached for details. Tolenix...
...development for the indications. TheraVida said it is pursuing an international Phase III program for Tolenix...
...royalties. TheraVida declined to disclose details, and SK Chemicals could not be reached for details. Tolenix...
...development for the indications. TheraVida said it is pursuing an international Phase III program for Tolenix...